Long-term results of a randomised phase III trial of weekly versus three-weekly paclitaxel/platinum induction therapy followed by standard or extended three-weekly paclitaxel/platinum in European patients with advanced epithelial ovarian cancer
van der Burg, M.E.L, Onstenk, W, Boere, I.A, Look, M, Ottevanger, P.B, de Gooyer, D, Kerkhofs, L.G.M, Valster, F.A.A, Ruit, J.B, van Reisen, A.G.P.M, Goey, S.H, van der Torren, A.M.E, ten Bokkel Huinink, D, Kok, T.C, Verweij, J, van Doorn, H.C
Published in European journal of cancer (1990) (01.10.2014)
Published in European journal of cancer (1990) (01.10.2014)
Get full text
Journal Article